PMC:7103735 / 36823-36994
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T372","span":{"begin":161,"end":170},"obj":"Disease"}],"attributes":[{"id":"A372","pred":"mondo_id","subj":"T372","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Administration of interferon ameliorated the severity of symptoms in 229E-challenged volunteers [58], suggesting that interferon confers protection against 229E infection."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T102","span":{"begin":18,"end":28},"obj":"Chemical"},{"id":"T103","span":{"begin":118,"end":128},"obj":"Chemical"}],"attributes":[{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"Administration of interferon ameliorated the severity of symptoms in 229E-challenged volunteers [58], suggesting that interferon confers protection against 229E infection."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T313","span":{"begin":0,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Administration of interferon ameliorated the severity of symptoms in 229E-challenged volunteers [58], suggesting that interferon confers protection against 229E infection."}
2_test
{"project":"2_test","denotations":[{"id":"32172672-6318655-27782260","span":{"begin":97,"end":99},"obj":"6318655"}],"text":"Administration of interferon ameliorated the severity of symptoms in 229E-challenged volunteers [58], suggesting that interferon confers protection against 229E infection."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1069","span":{"begin":161,"end":170},"obj":"Disease"}],"attributes":[{"id":"A1069","pred":"tao:has_database_id","subj":"1069","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Administration of interferon ameliorated the severity of symptoms in 229E-challenged volunteers [58], suggesting that interferon confers protection against 229E infection."}
MyTest
{"project":"MyTest","denotations":[{"id":"32172672-6318655-27782260","span":{"begin":97,"end":99},"obj":"6318655"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Administration of interferon ameliorated the severity of symptoms in 229E-challenged volunteers [58], suggesting that interferon confers protection against 229E infection."}